A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells

Growth Factors

Volumn 27, Issue 2, 2009, Pages 121-131

  Paul, Sangita ^a   Lee, John C ^a   Yeh, Lee Chuan C ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Bone marrow culture; Bone morphogenetic proteins; Gene expression; Osteoblast differentiation; Osteoclast differentiation

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; CATHEPSIN K; COLONY STIMULATING FACTOR 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; ACID PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; CATHEPSIN; ISOENZYME; RECOMBINANT PROTEIN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CULTURE; BONE MINERALIZATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STAINING; ANIMAL; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; CELL COUNT; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MURINAE; RATTUS;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE REMODELING; BONE RESORPTION; CATHEPSINS; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOBLASTS; OSTEOCLASTS; RANK LIGAND; RATS; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 66949121850     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802707324     Document Type: Article

References (55)

1. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC. 2000. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin. J Bone Miner Res 15:663-673.
2. Boissy P, Saltel F, Bouniol C, Jurdic P, Machuca-Gayet I. 2002. Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin. Endocrinology 143: 1913-1921.
3. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
4. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85- A:1544-1552.
5. Cook SD. 1999. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. [see comments] Orthopedics 22:669-671.
6. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425:577-584.
7. Ducy P, Schinke T, Karsenty G. 2000. The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:1501-1504.
8. Dudley AT, Lyons KM, Robertson EJ. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807.
9. Einhorn TA. 2003. Clinical applications of recombinant human BMPs: Early experience and future development. J Bone Joint Surg Am 85-A(Suppl. 3):82-88.
10. Einhorn TA, Lee CA. 2001. Bone regeneration: New findings and potential clinical applications. J Am Acad Orthop Surg 9: 157-165.
11. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83- A(Suppl. 1):S151-S158.
12. Geesink RG, Hoefnagels NH, Bulstra SK. 1999. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg [Br] 81:710-718.
13. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123-2134.
14. Hentunen TA, Lakkakorpi PT, Tuukkanen J, Lehenkari PP, Sampath TK, Vaananen HK. 1995. Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. Biochm Biophys Res Commun 209:433-443.
15. Hogan BL. 1996. Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432-438.
16. Irie K, Alpaslan C, Takahashi K, Kondo Y, Izumi N, Sakakura Y, Tsuruga E, Nakajima T, Ejiri S, Ozawa H, Yajima T. 2003. Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2). J Bone Miner Metab 21:363-369.
17. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. 2001. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kB ligand. Endocrinology 142: 3656-3662.
18. Jung RE, Glauser R, Scharer P, Hämmerle CHF, Sailer HF, Weber FE. 2003. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14:556-568.
19. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. 1995. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone resorbing activity. J Bone Miner Res 10: 1681-1690.
20. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. 2000. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27:479-486.
21. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, JiangW, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC. 2004. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11:1312-1320.
22. Kingsley DM. 1994. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
23. Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T. 1999. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 259:97-102.
24. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, Oh KO, Greene J, Li Y, Su J, Gentz R, Aggarwal BB, Ni J. 1998. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J 12:845-854.
25. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
26. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. 1995. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820.
27. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
28. Massague J. 2000. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1:169-178.
29. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. 1998. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
30. Okamoto M, Murai J, Yoshikawa H, Tsumaki N. 2006. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21:1022-1033.
31. Olsen BR, Reginato AM, Wang W. 2000. Bone development. Annu Rev Cell Dev Biol 16:191-220.
32. Otsuka E, Notoya M, Hagiwara H. 2003. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D induced formation of osteoclasts. Calcif Tissue Int 73:72-77.
33. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H. 1990. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9:2085-2093.
34. Quinn JM, Elliott J, Gillespie MT, Martin TJ. 1998. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427.
35. Reddi AH. 2000. Bone morphogenetic proteins and skeletal development: The kidney-bone connection. Pediatr Nephrol 14:598-601.
36. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robery PG, Teitelbaum SL, Cheresh DA. 1993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem 268:9901-9907.
37. 2 D3. J Bone Joint Surg Am 7:611-617.
38. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Ozkaynak E, Oppermann H, Rueger DC. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces newbone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362.
39. Simonet WS, Lacey DL, Dunstan CR, Kelley MJ, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
40. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270:9420-9428.
41. ten Dijke P, Hill CS. 2004. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29:265-273.
42. ten Dijke P, Fu J, Schaap P, Roelen BA. 2003. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85-A(Suppl. 3):34-38.
43. Teitelbaum SL. 2000. Bone resorption by osteolasts. Science 289:1504-1508.
44. Tolar J, Teitelbaum SL, Orchard PJ. 2004. Osteoporosis. New Engl J Med 351:2839-2849.
45. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142.
46. Tsumaki N, Yoshikawa H. 2005. The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16:279-285.
47. Valverde P, Tu Q, Chen J. 2005. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res 20:1669-1679.
48. Wan C, He Q, Li G. 2006. Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP-2 alone or together with rhVEGF. J Orthop Res 24:29-36.
49. Wildemann B, Kadow-Romacker A, Lubberstedt M, Raschke M, Haas NP, Schmidmaier G. 2005. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Calcif Tissue Int 76:50-55.
50. Wozney JM, Rosen V. 1998. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Rel Res 346:26-37.
51. Wutzl A, BrozekW, Lernbass I, Rauner M, Hofbauer G, Schopper C, Watzinger F, Peterlik M, Pietschmann P. 2006. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 77:75-83.
52. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K. 1998a. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
53. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998b. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
54. Yeh LC, Adamo ML, Olson MS, Lee JC. 1997. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 138:4181-4190.
55. YehL C, Tsai AD, Lee JC. 2002. Osteogenic protein-1 (OP-1,BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87:292-304.